MedBright AI Announces Strategic Investment into Algo8 Industrial AI
MedBright AI Investments Inc. (CSE:MBAI, OTCQB:MBAIF) has announced a strategic $900,000 investment in Algo8 Industrial AI Inc., acquiring an 11.25% stake at an $8 million pre-money valuation. The investment was funded through existing cash and sale of marketable securities.
Algo8, a global industrial AI pioneer with presence across India, UAE, UK, Netherlands, US, and Canada, has completed over 50 successful deployments worldwide. The company specializes in AI Digital Twins for real-time industrial simulations, Agentic AI for autonomous operations, and unified data platforms for industrial analytics.
The investment aims to accelerate the development of autonomous and sustainable factory solutions. Algo8's technology focuses on achieving zero-downtime manufacturing through predictive intelligence, implementing hyper-automation combining AI and robotics, and creating sustainable AI-driven industrial ecosystems with reduced resource footprints.
MedBright AI Investments Inc. (CSE:MBAI, OTCQB:MBAIF) ha annunciato un investimento strategico di 900.000 dollari in Algo8 Industrial AI Inc., acquisendo una partecipazione dell'11,25% a una valutazione pre-money di 8 milioni di dollari. L'investimento è stato finanziato tramite liquidità esistente e vendita di titoli negoziabili.
Algo8, un pioniere globale nell'AI industriale con presenza in India, UAE, Regno Unito, Paesi Bassi, Stati Uniti e Canada, ha completato oltre 50 implementazioni di successo in tutto il mondo. L'azienda si specializza in AI Digital Twins per simulazioni industriali in tempo reale, AI Agentic per operazioni autonome e piattaforme di dati unificate per analisi industriali.
L'investimento mira ad accelerare lo sviluppo di soluzioni per fabbriche autonome e sostenibili. La tecnologia di Algo8 si concentra sul raggiungimento di una produzione senza tempi di inattività attraverso l'intelligenza predittiva, implementando l'iperautomazione che combina AI e robotica, e creando ecosistemi industriali sostenibili guidati dall'AI con un ridotto impatto sulle risorse.
MedBright AI Investments Inc. (CSE:MBAI, OTCQB:MBAIF) ha anunciado una inversión estratégica de 900,000 dólares en Algo8 Industrial AI Inc., adquiriendo una participación del 11.25% a una valoración pre-money de 8 millones de dólares. La inversión se financió a través de efectivo existente y la venta de valores negociables.
Algo8, un pionero global en IA industrial con presencia en India, EAU, Reino Unido, Países Bajos, EE. UU. y Canadá, ha completado más de 50 implementaciones exitosas en todo el mundo. La empresa se especializa en gemelos digitales de IA para simulaciones industriales en tiempo real, IA agentiva para operaciones autónomas y plataformas de datos unificadas para análisis industriales.
La inversión tiene como objetivo acelerar el desarrollo de soluciones de fábricas autónomas y sostenibles. La tecnología de Algo8 se centra en lograr una fabricación sin tiempos de inactividad a través de inteligencia predictiva, implementando hiperautomatización que combina IA y robótica, y creando ecosistemas industriales sostenibles impulsados por IA con una menor huella de recursos.
MedBright AI Investments Inc. (CSE:MBAI, OTCQB:MBAIF)는 Algo8 Industrial AI Inc.에 90만 달러의 전략적 투자를 발표하며, 11.25%의 지분을 800만 달러의 기업 가치로 인수했습니다. 이 투자는 기존 현금과 유가증권 매각을 통해 자금을 조달했습니다.
Algo8은 인도, 아랍에미리트, 영국, 네덜란드, 미국 및 캐나다에 진출한 글로벌 산업 AI 선두주자로, 전 세계에서 50건 이상의 성공적인 배포를 완료했습니다. 이 회사는 실시간 산업 시뮬레이션을 위한 AI 디지털 트윈, 자율 운영을 위한 에이전틱 AI, 산업 분석을 위한 통합 데이터 플랫폼을 전문으로 합니다.
이번 투자의 목표는 자율적이고 지속 가능한 공장 솔루션의 개발을 가속화하는 것입니다. Algo8의 기술은 예측 지능을 통해 다운타임 없는 제조를 달성하고, AI와 로보틱스를 결합한 하이퍼 자동화를 구현하며, 자원 발자국을 줄인 지속 가능한 AI 기반 산업 생태계를 구축하는 데 중점을 두고 있습니다.
MedBright AI Investments Inc. (CSE:MBAI, OTCQB:MBAIF) a annoncé un investissement stratégique de 900 000 dollars dans Algo8 Industrial AI Inc., acquérant une participation de 11,25% à une valorisation pré-money de 8 millions de dollars. L'investissement a été financé par des liquidités existantes et la vente de titres négociables.
Algo8, un pionnier mondial de l'IA industrielle avec une présence en Inde, aux Émirats Arabes Unis, au Royaume-Uni, aux Pays-Bas, aux États-Unis et au Canada, a réalisé plus de 50 déploiements réussis dans le monde entier. L'entreprise se spécialise dans les jumeaux numériques IA pour des simulations industrielles en temps réel, l'IA agentique pour des opérations autonomes et des plateformes de données unifiées pour l'analyse industrielle.
L'investissement vise à accélérer le développement de solutions d'usine autonomes et durables. La technologie d'Algo8 se concentre sur l'atteinte d'une fabrication sans temps d'arrêt grâce à l'intelligence prédictive, en mettant en œuvre une hyper-automatisation combinant IA et robotique, et en créant des écosystèmes industriels durables pilotés par l'IA avec une empreinte de ressources réduite.
MedBright AI Investments Inc. (CSE:MBAI, OTCQB:MBAIF) hat eine strategische Investition von 900.000 US-Dollar in Algo8 Industrial AI Inc. angekündigt, wobei eine 11,25%-Beteiligung zu einer Pre-Money-Bewertung von 8 Millionen US-Dollar erworben wurde. Die Investition wurde aus vorhandenen Mitteln und dem Verkauf von handelbaren Wertpapieren finanziert.
Algo8, ein globaler Pionier im Bereich der industriellen KI mit Präsenz in Indien, den VAE, dem Vereinigten Königreich, den Niederlanden, den USA und Kanada, hat weltweit über 50 erfolgreiche Implementierungen abgeschlossen. Das Unternehmen ist auf KI-Digital Twins für Echtzeitsimulationen in der Industrie, Agentic AI für autonome Operationen und einheitliche Datenplattformen für industrielle Analysen spezialisiert.
Die Investition zielt darauf ab, die Entwicklung von autonomen und nachhaltigen Fabriklösungen zu beschleunigen. Die Technologie von Algo8 konzentriert sich darauf, eine Produktion ohne Ausfallzeiten durch prädiktive Intelligenz zu erreichen, Hyperautomatisierung zu implementieren, die KI und Robotik kombiniert, und nachhaltige, KI-gesteuerte industrielle Ökosysteme mit einem reduzierten Ressourcenverbrauch zu schaffen.
- Strategic acquisition of 11.25% stake in established AI company with 50+ deployments
- Investment funded through existing resources without additional debt
- Exposure to growing industrial AI market across multiple countries
- Diversification into high-growth technology sector
- Reduction in liquid assets and marketable securities to fund investment
- Minority stake position with control
- Early-stage investment with uncertain returns
VANCOUVER, British Columbia, March 03, 2025 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:Y30), a capital allocator focused on investing in diversified industries, is pleased to announce a strategic investment into Algo8 Industrial AI Inc. (“Algo8”), a global pioneer in industrial artificial intelligence. The Company believes that this milestone funding will accelerate the development of next-generation AI solutions with the aim of enabling a paradigm shift toward autonomous and sustainable factories of the future.
Algo8 strives to redefine industrial transformation with its innovative AI technologies. With a strong presence in India, UAE, UK, Netherlands, US, and Canada, Algo8 seeks to leverage this investment to drive innovation in AI-driven automation, sustainability, and operational intelligence. With over 50+ successful deployments worldwide, Algo8 has delivered AI innovations that enhance efficiency, boost profitability, and accelerate digital transformation.
MedBright on Strategic Investment
“MedBright's investment strategy centers on identifying and nurturing opportunities across a range of dynamic sectors,” said Brandon Kou Director of MedBright AI. “Our commitment to the AI landscape will be led by our investment into Algo8, a company that is not merely innovating, but also demonstrating a clear capacity for practical application and organizational adaptation, ensuring that technological progress translates into meaningful business transformation.”
Algo8 CEO on the Future of AI in Industry
“We believe we are entering the era of autonomous factories where AI-driven intelligence will redefine industrial efficiency and sustainability,” said Nandan Mishra, CEO of Algo8. “With this strategic investment, we will push the boundaries of our technology, making manufacturing smarter, faster, and more sustainable. Our mission is to shape the future of industrial AI and enable enterprises to unlock unrealized value.”
Algo8’s AI Digital Twins: The Engine of Smart Manufacturing
Algo8’s AI Digital Twins provide intelligent, real-time simulations of industrial environments, unlocking efficiency and agility. By integrating IoT, edge computing, and machine learning, these dynamic models anticipate system failures, optimize resource allocation, and enable human-AI collaboration. This evolution from predictive maintenance to autonomous operations is key to building future-ready smart factories.
Agentic AI: Empowering the Workforce of Tomorrow
Harnessing the power of Generative AI, Algo8’s industrial AI agents enrich human-machine synergy. These AI-powered assistants autonomously manage inventory, orchestrate production schedules, and optimize logistics, reducing operational bottlenecks. By augmenting human capabilities, Agentic AI fosters a highly adaptive, resilient, and efficient workforce, allowing industries to remain agile in a rapidly evolving landscape.
Unified Data Platforms: The Cognitive Core of Industry 4.0
Data is the foundation of intelligent decision-making. Algo8’s integrated data platforms function as the industrial nervous system, aggregating, harmonizing, and analyzing massive data streams in real time. By leveraging AI-powered analytics and cloud-edge integration, these platforms enable autonomous decision-making, drive sustainability metrics, and enhance production agility in dynamic environments.
Scaling Impact and Defining Industry Trends
It is anticipated this investment will fuel Algo8’s expansion into AI-powered industrial consulting and deployment, building on its proven success in industrial plants worldwide. The Company believes the future of manufacturing is autonomous, resilient, and sustainable, and Algo8 will be at the forefront of this revolution. The Algo8’s deep-tech AI solutions are already driving:
- zero-downtime manufacturing through predictive intelligence;
- hyper-automation that blends AI, robotics, and human expertise; and
- sustainable AI-driven industrial ecosystems with reduced energy and resource footprints.
Deal Terms
MedBright AI has invested
About MedBright AI Investments Inc.
MedBright AI is a capital allocator focused on investing in diversified industries, including technology, health care, and artificial intelligence. These include both public and private companies. MedBright has a focus on near-term and midterm high-quality opportunities with strong return potentials while maintaining its commitment to governance.
About Algo8
Algo8 is a global deep-tech pioneer in industrial AI, leveraging advanced machine learning, computer vision, and Generative AI to drive transformational impact across industries. With a multidisciplinary team of AI specialists, Algo8 is committed to building scalable, explainable, and responsible AI solutions that power the future of manufacturing, energy, and logistics.
With over 50+ successful deployments worldwide, Algo8 has consistently delivered breakthrough AI innovations that enhance efficiency, boost profitability, and accelerate digital transformation.
For further information, please contact:
MedBright AI Investments Inc.
Email: investors@medbright.ai
Phone: (604) 602-0001
www.medbright.ai
Cautionary Statement Regarding "Forward-Looking" Information
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance, including, without limitation, the anticipated benefits from the investment in Algo8, the goals, strategies and plans of Algo8, that the Company’s investment in Algo8 will lead the Company’s commitment to the AI landscape, the importance of AI technology in factories, and the Company’s beliefs around the future of manufacturing are forward-looking statements and contain forward-looking information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should” or “would” or occur.
Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including, among other things, that the investment will allow Algo8 to advance its technologies enabling a paradigm shift towards autonomous and sustainable factories in the future and expand into AI-powered industrial consulting and deployment, that Algo8 will continue to pursue the goals, strategies and plans outlined in this news release, that the Company will not make another investment that will lead its commitment to the AI landscape, that AI-driven intelligence will redefine industrial efficiency and sustainability, that Algo8’s technologies will result in the benefits currently expected by their management, that the evolution from predictive maintenance to autonomous operations will be key in building future-ready smart factories, and that Algo8 will be at the forefront of the autonomous, resilient and sustainable revolution in the manufacturing industry. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important risks that may cause actual results to vary, include, without limitation, that Algo8 will be unable to advance it technologies, that Algo8’s technologies will not result in the benefits expected, that Algo8 will not expand into AI-powered industrial consulting and deployment, that Algo8’s goals, strategies and plans will differ from its management’s current expectations, that the Company will make another investment to lead its commitment to the AI landscape, that AI-driven intelligence will not redefine industrial efficiency and sustainability, that the evolution from predictive maintenance to autonomous operations will not be key in building future-ready smart factories, and that Algo8 will not be at the forefront of the autonomous, resilient and sustainable revolution in the manufacturing industry.
Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.
FAQ
What is the size and valuation of MedBright AI's (MBAIF) investment in Algo8?
How many successful deployments has Algo8 completed globally?
What are the main technology solutions offered by Algo8 after MBAIF's investment?
How did MedBright AI (MBAIF) fund the Algo8 acquisition?
